Hims & Hers Health issues 0.00% convertible senior notes due 2032
What's the deal? Hims & Hers Health has issued 0.00% convertible senior notes due 2032, selling them to qualified institutional buyers under Rule 144A. The telehealth company also entered into capped call transactions with HSBCDealroom has a profile for this one. Try Dealroom →, BarclaysDealroom has a profile for this one. Try Dealroom →, BNP ParibasDealroom has a profile for this one. Try Dealroom →, and Morgan StanleyDealroom has a profile for this one. Try Dealroom → to limit shareholder dilution if the notes convert into equity.
The notes carry an initial conversion rate of 33.8590 shares of Class A common stock per $1,000 in principal, with a maximum rate of 44.8631 shares under certain scenarios. That means up to 18,057,397 new shares could be issued upon full conversion.
Why now? Hims & Hers has been on an aggressive growth trajectory in telehealth and direct-to-consumer health products. Zero-coupon convertible notes let the company raise capital without immediate cash interest payments — a useful tool for funding expansion while keeping short-term costs low.
The structure also signals confidence in its share price trajectory. Convertible notes at 0% interest only make sense for investors if they believe the stock will appreciate enough to make conversion worthwhile.
What could go wrong? The biggest risk is dilution. If the stock rises past the conversion price, noteholders will convert debt into equity, increasing the share count by up to roughly 18 million shares. The capped call transactions are designed to blunt this effect, but their effectiveness depends on where the stock trades at the time of conversion.
The notes also add leverage to the balance sheet. While there's no sinking fund requirement — meaning Hims & Hers doesn't have to set aside cash to redeem the notes at maturity — the debt still represents a real financial obligation that could constrain future flexibility.
Redemption and repurchase provisions tied to "fundamental change" events, such as a change of control or delisting, introduce additional event-driven risks. The company can only redeem the notes if at least $75M in principal remains outstanding, unless it redeems them all at once.
The signal: Hims & Hers' shift to zero-coupon convertible notes backed by HSBC, Barclays, BNP Paribas, and Morgan Stanley — all major corporate and institutional investors — underscores how far the company has moved beyond its venture-backed origins into late-growth-stage capital markets. The involvement of four heavyweight counterparties in the capped call transactions suggests broad institutional conviction that the telehealth platform's equity story can sustain a long-dated bet through 2032.
Read more: minichart.com.sg
